FDAnews Announces — Increase Compliance, Reduce Risk with Integrated Digital Solutions: Create a Connected System and Streamline Your Operations Webinar, Nov. 26, 2019

19:00 EST 13 Nov 2019 | PR Web

Want to be first to market with a pharma or medical device product? Integrate digital solutions to streamline operations.

FALLS CHURCH, Va. (PRWEB) November 13, 2019

First to market: A coveted spot one aspires to reach in the crowded life sciences arena. There are multiple SOPs in place to improve efficiency and ease of use, in an effort to minimize wasted time and win that sought-after place.

But one is far more likely to be first to market when SOPs and digital solutions are integrated, ensuring nothing falls through the cracks. After all, if one doesn’t know there’s a problem, one can’t address it.

Patricia Santos-Serrao, RAC — Director, Product Strategy at MasterControl — explains that, while individual systems are each valuable alone, when targeted tools are integrated, they offer benefits that are exponentially powerful. Especially since 80% of quality issues are due to inefficient corrective action from previously identified issues.

Connected technology — the integration of electronic document management, training management, risk mitigation, risk management, deviation and CAPA management, and audit management systems — will trigger the kinds of checks and balances across systems that increase compliance and reduce risk.

Attend this session to:

  • Save time and money by streamlining processes, automating and consolidating tasks
  • Build a robust risk management protocol that automates vital actions in other systems
  • Optimize document controls to automatically trigger important updates that might otherwise take weeks to notice
  • Implement a learning management system that goes beyond “read and understood” to ensure compliance
  • Ensure audit tools are flexible and powerful enough to capture compliance issues meaningfully, both internally and externally
  • Create an integrated document control and training management strategy to take advantage of automation features of technology
  • Incorporate business processes into technology to automate tasks and reduce risk of critical tasks being missed

Win that coveted first-to-market spot. Integrate digital solutions, streamline operations, improve quality and mitigate risk. First to market is just around the corner.

Interested in registering multiple sites?
Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally
to learn about our special multisite discount.

Webinar Details:
Increase Compliance, Reduce Risk with Integrated Digital Solutions
Create a Connected System and Streamline Your Operations
An FDAnews/CenterWatch Webinar
Tuesday, Nov. 26, 2019, 1:30-3:00 p.m. EST

$287 per site

Easy Ways to Register:
By phone: 888-838-5578 or 703-538-7600

About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations

For the original version on PRWeb visit:


More From BioPortfolio on "FDAnews Announces — Increase Compliance, Reduce Risk with Integrated Digital Solutions: Create a Connected System and Streamline Your Operations Webinar, Nov. 26, 2019"

Quick Search

Relevant Topics

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...